Lv3
290 积分 2024-12-25 加入
Postsurgical circulating tumor DNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinoma
6个月前
已关闭
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group
7个月前
已完结
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
7个月前
已完结
Circulating tumor DNA as a biomarker in early phase clinical trials
7个月前
已完结
A Multicenter Study of Hereditary Transthyretin Amyloidosis in China
7个月前
已完结
Precision Oncology: 2025 in Review
8个月前
已完结
Expression of cluster of differentiation 47 (CD47) and signal regulatory protein alpha (SIRPα) as prognostic biomarkers and potentially therapeutic targets in esophageal squamous cell carcinoma
9个月前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
9个月前
已完结
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
9个月前
已完结
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
10个月前
已完结
皖公网安备34019202002308
